| KOTAK HEALTHCARE FUND
An open ended equity scheme investing in Pharma, Healthcare & allied sectors.
| KOTAK HEALTHCARE FUND
An open ended equity scheme investing in Pharma, Healthcare & allied sectors.

  

  
Investment Objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved.

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved.


Issuer/Instrument
% to Net
Assets

Equity & Equity related
Pharmaceuticals and Biotechnology 71.47
Sun Pharmaceuticals Industries Ltd. 15.44
Divi s Laboratories Ltd. 6.09
Cipla Ltd. 5.06
JUBILANT PHARMOVA LIMITED 3.78
JB CHEMICALS & PHARMACEUTICALS LTD. 3.66
Lupin Ltd. 3.24
Torrent Pharmaceuticals Ltd. 3.07
DR REDDYS LABORATORIES LTD. 2.88
Alkem Laboratories Ltd. 2.82
Aurobindo Pharma Ltd. 2.67
Marksans Pharma Ltd 2.65
Zydus Lifesciences Limited 2.46
AMI ORGANICS LTD 2.44
Ajanta Pharma Ltd. 2.28
MANKIND PHARMA LTD 2.27
SAI LIFE SCIENCES LIMITED 2.18
Glenmark Pharmaceuticals Ltd 1.91
INNOVA CAPTABS LTD 1.86
HIKAL LTD 1.80
GLAND PHARMA LIMITED 1.46
ORCHID PHARMA LTD. 1.45
Healthcare Services 21.58
MAX HEALTHCARE INSTITUTE LTD. 7.90
Apollo Hospitals Enterprises Ltd. 3.17
ASTER DM HEALTHCARE LTD 2.77
KRISHNA INSTITUTE OF MEDICAL 2.36
YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD 1.96
Fortis Healthcare India Ltd 1.95
KRSNAA DIAGNOSTICS LTD 1.47
Healthcare Equipment and Supplies 1.85
LAXMI DENTAL LIMITED 1.85
Equity & Equity related - Total 94.90
Triparty Repo 6.01
Net Current Assets/(Liabilities) -0.91
Grand Total 100.00



Systematic Investment Plan (SIP) If you had invested Rs 10,000 every month
Monthly SIP of Rs 10000 Since Inception 1 Year
Total amount invested (₹) 1,80,000 1,20,000
Total Value as on May 30, 2025 (₹) 1,93,036 1,21,021
Scheme Returns (%) 9.25 1.60
Nifty Healthcare Index (TRI) Returns (%) 11.42 3.16
Alpha* -2.17 -1.56
Nifty Healthcare Index (TRI) (₹)# 1,96,095 1,22,011
Nifty 50 (TRI) (₹)^ 1,93,082 1,24,417
Nifty 50 (TRI) Returns (%) 9.28 6.98

Scheme Inception : - December 11, 2023. The returns are calculated by XIRR approach assuming investment of ₹10,000/- on the 1st working day of every month. Since Inception returns are assumed to be starting from the inception date of the Scheme and calculated accordingly. XIRR helps in calculating return on investments given an initial and final value and a series of cash inflows and outflows and taking the time of investment into consideration. The SIP performance details provided herein are of Regular Plan - Growth Option Different plans have different expense structure. # Benchmark; ^ Additional Benchmark. TRI – Total Return Index, In terms of para 6.14 of SEBI Master circular No. SEBI/HO/IMD/IMD-PoD-1/P/CIR/2024/90 dated June 27, 2024, the performance of the scheme is benchmarked to the Total Return variant (TRI) of the Benchmark Index instead of Price Return Variant (PRI). Alpha is difference of scheme return with benchmark return. *All payouts during the period have been reinvested in the units of the scheme at the then prevailing NAV. Source: ICRA MFI Explorer.

Net Asset Value (NAV)
RegularDirect
Growth Rs12.9660Rs13.2840
IDCW Rs12.9700Rs13.2830
(as on May 30, 2025)

Available Plans/Options

A) Regular Plan B) Direct Plan
Options: Growth and Income Distribution cum capital withdrawal (IDCW) (Payout and Reinvestment)


Fund Manager* Ms. Shibani Sircar Kurian,
Mr. Abhishek Bisen &
Mr. Dhananjay Tikariha
BenchmarkNifty Healthcare Index TRI
Allotment dateDecember 11, 2023
AAUMRs419.06 crs
AUMRs434.55 crs
Folio count32,949

IDCW Frequency

Trustee's Discretion


Ratios
Portfolio Turnover36.79%
$Beta0.96
$Sharpe ##0.69
$Standard Deviation18.08%
^^(P/E) 37.76
^^P/BV 5.20
Source: $ICRA MFI Explorer, ^^Bloomberg

Market Capitalisation*
Large Cap35.00%
Mid Cap28.21%
Small Cap31.69%
Debt & Money Market5.10%

*% of Net Asset

Minimum Investment Amount

Initial & Additional Investment
• Rs100 and any amount thereafter
Systematic Investment Plan (SIP)
• Rs 100 and any amount thereafter

Ideal Investments Horizon

• 5 years & above


Load Structure

Entry Load: Nil. (applicable for all plans)
Exit Load:
• For redemption / switch out within 30 days from the date of allotment: 0.5%
• If units are redeemed or switched out on or after 30 days from the date of allotment: NIL


Total Expense Ratio**
Regular Plan: 2.40%
Direct Plan: 0.80%

Data as on 31st May, 2025 unless otherwise specified.

Folio Count data as on 30th April 2025.

Fund


Benchmark : Nifty Healthcare Index TRI
This product is suitable for investors who are seeking*:
  • Long-term capital growth
  • Investment in portfolio of predominantly equity & equity related securities of companies engaged in Pharma, Healthcare & allied sectors.

* Investors should consult their financial advisors if in doubt about whether the product is suitable for them.

For latest Riskometer, investors may refer to an addendum issued or updated on website at www.kotakmf.com

## Risk rate assumed to be 5.86% (FBIL Overnight MIBOR rate as on 30th May 2025). **Total Expense Ratio includes applicable B30 fee and GST.
* For Fund Manager experience, please refer 'For Regular Plan' & 'For Direct Plan'
For scheme performance, please refer 'For Regular Plan' & 'For Direct Plan'